Clinical Trials Browser

Phase 2 × Has results × Spironolactone × Clear all

NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Phase 2 Completed

19 enrolled 9 charts

Advanced Malignant Neoplasm